Compare Home Depot Inc (HD) vs Oscar Health Inc (OSCR) Price & Performance

Home Depot (HD) trades at $285.77, down 0.32% with bearish technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 104.3%, net margin 8.41%). Revenue grew to $159.51B in 2025, though margins face pressure from housing market headwinds. Analysts maintain a bullish consensus with a $379.93 price target (58.7% buy ratings). Recent institutional activity shows mixed positioning amid weak big-ticket demand.

HD offers long-term value with analyst upside of 33% but faces near-term risks from rising mortgage rates and margin compression. The Pro business and digital initiatives provide growth levers, while technical weakness suggests cautious entry points. Investors should weigh strong cash flow generation against cyclical housing exposure.

Oscar Health (OSCR) trades at $32.91, up 1.76% with strong technical momentum and bullish moving average signals. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, with profitability turning positive at $551M net income. Recent earnings beats and raised guidance have driven positive sentiment, though the stock faces challenges from rising medical costs and competitive pressures in the ACA market.

The outlook remains constructive with analyst consensus at $34.00 and strong institutional interest, though investors should monitor execution risks and medical cost trends. The combination of market share gains, margin expansion potential, and bullish technical setup supports further upside if the company can maintain its growth trajectory.